Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

Pennsylvania Governor Wolf Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

July 22, 2016

BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.

BIO Statement on Prescription Drug User Fee Act Goals Letter

July 15, 2016

Washington, D.C. (July 15, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding the Prescription Drug User Fee Act (PDUFA) VI goals letter:

BIO and Nikon Instruments Inc. Jointly announce a new Program for Research Grade Microscope System for BIO Members

July 15, 2016

BIO and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.

BIO Applauds Advancement of H.R. 3299

July 14, 2016

Statement on House Energy & Commerce Committee Passage of H.R. 3299, the Strengthening Public Health Emergency Response Act of 2016

BIO Applauds Passage of Federal Approach to GMO Disclosure

July 14, 2016

Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure.

BIO Submits Comments on Proposed 2017 Renewable Fuel Standards

July 11, 2016

BIO today submitted comments on EPA's proposed Renewable Fuel Standards for 2017, demonstrating that EPA’s interpretation of statutory waiver authority is flawed and its proposed volumes of renewable fuel available for the program are too low and…

BIO Congratulates Senate on Passage of GMO Disclosure Package

July 8, 2016

BIO applauds and commends the U.S. Senate for approving the bipartisan Roberts-Stabenow GMO labeling and disclosure solution.

BIO Applauds Senate Support of GMO Disclosure Package

July 7, 2016

Food and ag groups urge Senate passage this weekWashington, D.C. (July 7, 2016) – The Biotechnology Innovation Organization (BIO) joins more than a thousand food and agriculture organizations from across the country in applauding action in the U.S…

BIO Response to Hillary Clinton’s Initiative on Technology & Innovation

June 28, 2016

BIO welcomes many of the broad proposals put forth in Secretary Clinton’s Tech & Innovation Agenda and we share her optimism in the power of American innovation and ingenuity to address global health, environmental and food-supply challenges.

BIO Thanks Senators for Supporting Higher RFS Volumes

June 24, 2016

Today, a bipartisan group of 39 Senators -- led by Sens. Charles Grassley (R-IA), Amy Klobuchar (D-MN) -- urged EPA to get the Renewable Fuel Standard (RFS) “back on track by setting blending targets where Congress intended and by removing the…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.